Showing posts with label Genetics. Show all posts
Showing posts with label Genetics. Show all posts

Friday, March 29, 2019

Precision Medicine: What it Mean for Your Health?

Precision Medicine is an approach that permits doctors to choose treatments by understanding the genetic cause of patient sickness. Precision medicine, sometimes called personalized medicine, is an approach for protecting the health and treating a disease that considers a person’s genes, behaviors, and environment. Precision drugs are most popular in areas of cancer analysis. Immunotherapy is a new approach that harnesses the power of our immune systems to identify and control diseases such as cancer. Using the genetic changes in the patient,  their treatment is understood.



Precision genetics provides a customized approach to testing, diagnosing, and treating cancer. Instead of employing a one-size-fits-all approach  here are some ways in which a precision drug approach will shield your health:
Predict susceptibility to disease
Improve disease detection
Pre-empt disease progression
Customize disease-prevention strategies
Prescribe more effective drugs
Avoid prescribing drugs with predictable side effects

The ancient follow usually misses its mark - every person’s genetic makeup is completely different from others,  which have a vital effect on health. Our understanding of genetics and the way they drive health, sickness and drug responses in everyone make doctors supply higher sickness interference, more correct diagnoses, safer drug prescriptions and simpler treatments for the numerous diseases and conditions that diminish our health. Tailoring health care to every person’s distinctive genetic makeup – that’s the promising plan behind Precision Drugs.


Uses Family Health History
Screen for Diseases Before You Get Sick
Tailoring Prevention
Tailoring Treatments
Finding and Tracking Infectious Diseases
Eliminate trial-and-error inefficiencies that inflate health care prices and undermine patient care.

Throughout history, the follow of traditional medication has mostly been reactive. Even today, we tend to wait till the onset of diseases then attempts to treat or cure them. Our efforts to treat these major diseases like Cancer, Alzheimer’s and diabetes which are caused by Genetic and environmental factors are often imprecise, unpredictable and ineffective.

The drugs and treatments we devise are tested on broad populations and are prescribed using statistical averages. Consequently, they work for a few patients not for several others, due to genetic differences among the population. On average, any given medicinal drug currently on the market solely works for half people.

Tuesday, March 19, 2019

The Promise of Bio markers in Cancer detection

Recent developments, Current trends and Future directions

One of the vital factors for the survival of cancer is detection at an early stage. Clinical assays diagnose events of cancer and stop cancer progression. Biomarkers measure molecular signatures of a cell that aid in early cancer detection and risk assessment. Cancer biomarkers are DNA, mRNA, proteins, metabolites, or processes like cell death, growth or proliferation. The markers are made either by the neoplasm itself or by alternative tissues, in response to the presence of cancer or alternative associated conditions, like inflammation. Such biomarkers are often found in fluids, tissues and cell lines.
Biomarkers give a robust and dynamic approach to understanding the spectrum of malignancies.T he goals in cancer analysis in finding biomarkers may be used for the first detection of cancers, individual therapies, and to spot underlying processes concerned the sickness.
In spite of advances, cancer remains the second leading reason behind death. Successful cancer treatment depends not solely on therapies but also on improved strategies to find cancers at early stages. Current cancer diagnostic imaging strategies are labour-intensive and expensive, particularly for screening massive populations. So, there is increasing interest in molecular markers as tools for cancer detection and prognosis.

It is hoped that high-throughput technologies would revolutionize cancer therapies by rising cancer risk assessment, early detection, diagnosis, and prognosis.  Biomarkers embrace genes and genetic variations.  By analysing biomarkers, diagnostic tests can able to give info regarding early tumour development to find cancer at the treatable stage.
These biomarkers will be useful in managing patients with the following settings:
  • Risk Assessment
  • Screening/Detection
  • Diagnosis
  • Prognosis
  • Prediction
  • Monitoring
We are delighted to welcome all participants to enjoy a rich, varied and attractive scientific and cultural program. We cordially wish you benefit from pleasant interactions with colleagues and carry home good memories of the 4th International Conference on Molecular Medicine and Diagnostics at Abu Dhabi, UAE.